The Centers for Medicare & Medicaid Services (CMS) has added several changes to the Medicare price negotiation process ...

Kurma plans to raise a total of 250 million euros ($276 million) for the fund, dubbed Biofund IV, which would make it the ...

Septerna is about to find out how a biotech without “any meaningful clinical data” fares in the late 2024 IPO market. | ...

Jefferies analyst Peter Welford maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of £114.00.

The solution will use Owkin's data network and artificial intelligence to prescreen for gBRCA mutations in breast cancer directly from digital pathology slides.

Bill Gates visiting TerraPower Isotopes, the subsidiary of the nuclear power company TerraPower that he helped found. Gates ...

Santa Barbara, Calif.– 2024 October 2 –Rupa Dainer, MD, U.S. Navy veteran and medical director, senior patient safety physician of ...

After 19 weeks on daily oral HU6 treatment, people shed on average 2.9 kg (~6.3 lb) or 2.7% of their starting body weight ...

Wednesday announced a clinical trial collaboration agreement with AstraZeneca (AZN) to evaluate casdatifan in combination with volrustomig for the treatment of clear cell renal cell carcinoma or ccRCC ...

Beyonce’s father, Mathew Knowles, is sharing the details of his breast cancer journey to help raise awareness about the early ...

Ever wondered what one of the world’s top oncology leaders believe to be the next big thing in cancer care? Find out in our interview AstraZeneca's Dr Sunil Verma.

Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, is pleased to ...